Clinical Trial: Levetiracetam for Benign Rolandic Epilepsy

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Efficacy of Levetiracetam for Language Dysfunction Associated With Benign Epilepsy With Centrotemporal Spikes

Brief Summary: This study is designed to test if the language problems commonly seen in children with benign rolandic epilepsy would improve by switching anticonvulsants to levetiracetam.

Detailed Summary: This is a 6 month study in which children on another anticonvulsant would have EEG, language testing, and a clinic visit at baseline. They would then be rapidly transitioned off of their current anticonvulsant and onto levetiracetam (Keppra). Repeat EEG and language testing would be done after 6 months to evaluate for improvement.
Sponsor: Johns Hopkins University

Current Primary Outcome: Language improvement

Original Primary Outcome: Same as current

Current Secondary Outcome: Seizure control

Original Secondary Outcome: Same as current

Information By: Johns Hopkins University

Dates:
Date Received: September 10, 2005
Date Started: March 2005
Date Completion:
Last Updated: March 26, 2009
Last Verified: March 2009